168 related articles for article (PubMed ID: 28370217)
1. The sensitivity of glioma cells to pyropheophorbide-αmethyl ester-mediated photodynamic therapy is enhanced by inhibiting ABCG2.
Pan L; Lin H; Tian S; Bai D; Kong Y; Yu L
Lasers Surg Med; 2017 Sep; 49(7):719-726. PubMed ID: 28370217
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the Effect of Methyl Pyropheophorbide-a-Mediated Photodynamic Therapy was Achieved by Increasing ROS through Inhibition of Nrf2-HO-1 or Nrf2-ABCG2 Signaling.
Tian S; Yong M; Zhu J; Zhang L; Pan L; Chen Q; Li KT; Kong YH; Jiang Y; Yu TH; Yu LH; Bai DQ
Anticancer Agents Med Chem; 2017; 17(13):1824-1836. PubMed ID: 28356018
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of human osteosarcoma cells resistant to pyropheophorbide-α methyl ester-mediated photodynamic therapy.
Tao Y; Ou Y; Yin H; Chen Y; Zhong S; Gao Y; Zhao Z; He B; Huang Q; Deng Q
Int J Oncol; 2017 Nov; 51(5):1427-1438. PubMed ID: 29048645
[TBL] [Abstract][Full Text] [Related]
4. Pyropheophorbide-α methyl ester-mediated photodynamic therapy induces apoptosis and inhibits LPS-induced inflammation in RAW264.7 macrophages.
Huang L; Chen Q; Yu L; Bai D
Photodiagnosis Photodyn Ther; 2019 Mar; 25():148-156. PubMed ID: 30562579
[TBL] [Abstract][Full Text] [Related]
5. ABCG2-mediated suppression of chlorin e6 accumulation and photodynamic therapy efficiency in glioblastoma cell lines can be reversed by KO143.
Abdel Gaber SA; Müller P; Zimmermann W; Hüttenberger D; Wittig R; Abdel Kader MH; Stepp H
J Photochem Photobiol B; 2018 Jan; 178():182-191. PubMed ID: 29156346
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis and autophagy induced by pyropheophorbide-α methyl ester-mediated photodynamic therapy in human osteosarcoma MG-63 cells.
Huang Q; Ou YS; Tao Y; Yin H; Tu PH
Apoptosis; 2016 Jun; 21(6):749-60. PubMed ID: 27108344
[TBL] [Abstract][Full Text] [Related]
7. YAP knockdown in combination with ferroptosis induction increases the sensitivity of HOS human osteosarcoma cells to pyropheophorbide-α methyl ester-mediated photodynamic therapy.
Zhan F; Zhang Y; Zuo Q; Xie C; Li H; Tian L; Wu C; Chen Z; Yang C; Wang Y; Li Q; He T; Yu H; Chen J; Xiang J; Ou Y
Photodiagnosis Photodyn Ther; 2022 Sep; 39():102964. PubMed ID: 35705143
[TBL] [Abstract][Full Text] [Related]
8. MPPa-PDT suppresses breast tumor migration/invasion by inhibiting Akt-NF-κB-dependent MMP-9 expression via ROS.
Huang L; Lin H; Chen Q; Yu L; Bai D
BMC Cancer; 2019 Nov; 19(1):1159. PubMed ID: 31783821
[TBL] [Abstract][Full Text] [Related]
9. Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug.
Selbo PK; Weyergang A; Eng MS; Bostad M; Mælandsmo GM; Høgset A; Berg K
J Control Release; 2012 Apr; 159(2):197-203. PubMed ID: 22349185
[TBL] [Abstract][Full Text] [Related]
10. ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy.
Robey RW; Steadman K; Polgar O; Bates SE
Cancer Biol Ther; 2005 Feb; 4(2):187-94. PubMed ID: 15684613
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of one- and two-photon activated photodynamic therapy with pyropheophorbide-a methyl ester in human cervical, lung and ovarian cancer cells.
Luo T; Wilson BC; Lu QB
J Photochem Photobiol B; 2014 Mar; 132():102-10. PubMed ID: 24607610
[TBL] [Abstract][Full Text] [Related]
12. Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.
Hagiya Y; Endo Y; Yonemura Y; Takahashi K; Ishizuka M; Abe F; Tanaka T; Okura I; Nakajima M; Ishikawa T; Ogura S
Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):204-14. PubMed ID: 22959800
[TBL] [Abstract][Full Text] [Related]
13. The ABCG2 transporter is a key molecular determinant of the efficacy of sonodynamic therapy with Photofrin in glioma stem-like cells.
Xu ZY; Wang K; Li XQ; Chen S; Deng JM; Cheng Y; Wang ZG
Ultrasonics; 2013 Jan; 53(1):232-8. PubMed ID: 22771084
[TBL] [Abstract][Full Text] [Related]
14. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic effects of pyropheophorbide-a methyl ester in nasopharyngeal carcinoma cells.
Xu CS; Leung AW
Med Sci Monit; 2006 Aug; 12(8):BR257-62. PubMed ID: 16865057
[TBL] [Abstract][Full Text] [Related]
16. The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2.
Liu W; Baer MR; Bowman MJ; Pera P; Zheng X; Morgan J; Pandey RA; Oseroff AR
Clin Cancer Res; 2007 Apr; 13(8):2463-70. PubMed ID: 17438106
[TBL] [Abstract][Full Text] [Related]
17. Enhanced efficacy of photodynamic therapy by inhibiting ABCG2 in colon cancers.
Kim JH; Park JM; Roh YJ; Kim IW; Hasan T; Choi MG
BMC Cancer; 2015 Jul; 15():504. PubMed ID: 26149077
[TBL] [Abstract][Full Text] [Related]
18. ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells.
Müller P; Abdel Gaber SA; Zimmermann W; Wittig R; Stepp H
J Photochem Photobiol B; 2020 Sep; 210():111963. PubMed ID: 32795847
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.
Usuda J; Tsunoda Y; Ichinose S; Ishizumi T; Ohtani K; Maehara S; Ono S; Tsutsui H; Ohira T; Okunaka T; Furukawa K; Sugimoto Y; Kato H; Ikeda N
Lung Cancer; 2010 Feb; 67(2):198-204. PubMed ID: 19477032
[TBL] [Abstract][Full Text] [Related]
20. [Induction of Apoptosis of Human Cisplatin-resistance Lung Cancer Cells with MPPa-photodynamic Therapy].
Luo L; Yu T; Bai D; Hu L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Aug; 33(4):729-34. PubMed ID: 29714913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
